Trial Profile
Effect of adiponectin genetic polymorphism on rosiglitazone response
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacogenomic; Therapeutic Use
- 13 Aug 2007 New trial record.